These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12167121)

  • 1. Beta-catenin expression in hepatocellular carcinoma: a possible participation of beta-catenin in the dedifferentiation process.
    Suzuki T; Yano H; Nakashima Y; Nakashima O; Kojiro M
    J Gastroenterol Hepatol; 2002 Sep; 17(9):994-1000. PubMed ID: 12167121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Nodule-in-nodule' appearance in hepatocellular carcinoma: its significance as a morphologic marker of dedifferentiation.
    Kojiro M
    Intervirology; 2004; 47(3-5):179-83. PubMed ID: 15383727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression patterns of E-cadherin and beta-catenin according to clinicopathological characteristics of hepatocellular carcinoma].
    Bae SH; Jung ES; Park YM; Jang JW; Choi JY; Cho SH; Yoon SK; Ahn BM; Cha SB; Chung KW; Sun HS; Park DH; Kim BK; Kim DG
    Taehan Kan Hakhoe Chi; 2002 Sep; 8(3):297-303. PubMed ID: 12499787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and prognostic roles of beta-catenin in hepatocellular carcinoma: correlation with tumor progression and postoperative survival.
    Inagawa S; Itabashi M; Adachi S; Kawamoto T; Hori M; Shimazaki J; Yoshimi F; Fukao K
    Clin Cancer Res; 2002 Feb; 8(2):450-6. PubMed ID: 11839663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear accumulation of mutated beta-catenin in hepatocellular carcinoma is associated with increased cell proliferation.
    Nhieu JT; Renard CA; Wei Y; Cherqui D; Zafrani ES; Buendia MA
    Am J Pathol; 1999 Sep; 155(3):703-10. PubMed ID: 10487827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of E-cadherin and I-catenin in human hepatocellular carcinoma cell lines by sodium butyrate and interferon-alpha.
    Masuda T; Saito H; Kaneko F; Atsukawa K; Morita M; Inagaki H; Kumagai N; Tsuchimoto K; Ishii AH
    In Vitro Cell Dev Biol Anim; 2000 Jun; 36(6):387-94. PubMed ID: 10949998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-myc downstream regulated gene 1 (NDRG1)/Cap43 enhances portal vein invasion and intrahepatic metastasis in human hepatocellular carcinoma.
    Akiba J; Ogasawara S; Kawahara A; Nishida N; Sanada S; Moriya F; Kuwano M; Nakashima O; Yano H
    Oncol Rep; 2008 Dec; 20(6):1329-35. PubMed ID: 19020710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of beta-catenin in hepatocellular carcinoma.
    Tien LT; Ito M; Nakao M; Niino D; Serik M; Nakashima M; Wen CY; Yatsuhashi H; Ishibashi H
    World J Gastroenterol; 2005 Apr; 11(16):2398-401. PubMed ID: 15832407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor heterogeneity in small hepatocellular carcinoma: analysis of tumor cell proliferation, expression and mutation of p53 AND beta-catenin.
    An FQ; Matsuda M; Fujii H; Tang RF; Amemiya H; Dai YM; Matsumoto Y
    Int J Cancer; 2001 Aug; 93(4):468-74. PubMed ID: 11477549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gross appearance of hepatocellular carcinoma reflects E-cadherin expression and risk of early recurrence after surgical treatment.
    Inayoshi J; Ichida T; Sugitani S; Tsuboi Y; Genda T; Honma N; Asakura H
    J Gastroenterol Hepatol; 2003 Jun; 18(6):673-7. PubMed ID: 12753149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mode of tumour progression in combined hepatocellular carcinoma and cholangiocarcinoma: an immunohistochemical analysis of E-cadherin, alpha-catenin and beta-catenin.
    Asayama Y; Taguchi Ki K; Aishima Si S; Nishi H; Masuda K; Tsuneyoshi M
    Liver; 2002 Feb; 22(1):43-50. PubMed ID: 11906618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of E-cadherin, alpha-catenin and beta-catenin expression in neuroendocrine tumors of the gastrointestinal tract.
    Li CC; Xu B; Hirokawa M; Qian Z; Yoshimoto K; Horiguchi H; Tashiro T; Sano T
    Virchows Arch; 2002 Feb; 440(2):145-54. PubMed ID: 11964044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the expression of beta-catenin in hepatocellular carcinoma in areas with high and low levels of exposure to aflatoxin B1.
    Chen Ban K; Singh H; Krishnan R; Fong Seow H
    J Surg Oncol; 2004 Jun; 86(3):157-63. PubMed ID: 15170655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathology of early hepatocellular carcinoma: progression from early to advanced.
    Kojiro M
    Hepatogastroenterology; 1998 Aug; 45 Suppl 3():1203-5. PubMed ID: 9730375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of mutant nuclear beta-catenin correlates with non-invasive hepatocellular carcinoma, absence of portal vein spread, and good prognosis.
    Mao TL; Chu JS; Jeng YM; Lai PL; Hsu HC
    J Pathol; 2001 Jan; 193(1):95-101. PubMed ID: 11169521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-catenin accumulation in the progression of human hepatocarcinogenesis correlates with loss of E-cadherin and accumulation of p53, but not with expression of conventional WNT-1 target genes.
    Prange W; Breuhahn K; Fischer F; Zilkens C; Pietsch T; Petmecky K; Eilers R; Dienes HP; Schirmacher P
    J Pathol; 2003 Oct; 201(2):250-9. PubMed ID: 14517842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis.
    Hsu HC; Jeng YM; Mao TL; Chu JS; Lai PL; Peng SY
    Am J Pathol; 2000 Sep; 157(3):763-70. PubMed ID: 10980116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GSK-3beta phosphorylation and alteration of beta-catenin in hepatocellular carcinoma.
    Ban KC; Singh H; Krishnan R; Seow HF
    Cancer Lett; 2003 Sep; 199(2):201-8. PubMed ID: 12969793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal beta-catenin gene expression with invasiveness of primary hepatocellular carcinoma in China.
    Cui J; Zhou XD; Liu YK; Tang ZY; Zile MH
    World J Gastroenterol; 2001 Aug; 7(4):542-6. PubMed ID: 11819825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation and overexpression of the beta-catenin gene may play an important role in primary hepatocellular carcinoma among Chinese people.
    Cui J; Zhou X; Liu Y; Tang Z
    J Cancer Res Clin Oncol; 2001 Sep; 127(9):577-81. PubMed ID: 11570580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.